Purchase Order 75F40122P00453

The Department of Health and Human Services Food and Drug Administration awarded a $25,025 firm fixed price purchase order to Nanocomposix, LLC for the production of amino-functionalized silica nanoparticles for in vivo analysis of blood-brain barrier safety and integrity. Performance will take place in Silver Spring, Maryland by September 15, 2023. No set-aside designation was applied to this contract for Nanocomposix to deliver amino-functionalized silica nanoparticles to the FDA, presumably...

This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Nanion Technologies Inc., a for-profit corporation that provides scientific instruments and services related to ion channel drug discovery. The $114,374.00 firm fixed-price contract is for the delivery of a Patch Clamp Rig (Port-A-Patch) and a Bilayer Recording Station (Orbit Mini) to support the National Institute of Neurological Disorders and Stroke's...

This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PGI Holding Corporation, a for-profit subchapter S corporation, to evaluate the efficacy of a nanoparticle formulation containing the drug aprepitant in a rodent model of neuropathic pain. The contract, valued at $216,900.00, has a period of performance from September 20, 2021 to March 31,...

This firm fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), to the University of Massachusetts Medical School (UMass Medical) for the delivery of 15 adeno-associated virus (AAV) serotype 9 preps expressing human codon-optimized mMut and MMAB donor sequences. The $46,379 contract supports NCATS' Platform Vector Gene Therapy project and will be used to test gene therapy strategies in disease model...

Nanopharm LIMITED was awarded a definitive cost-no-fee contract valued at one hundred twenty-nine thousand four hundred sixty-nine dollars by the Department of Health and Human Services Food and Drug Administration to support the agency's PMQWP 202 broad agency announcement. Under the contract, Nanopharm will perform work investigating orthogonal analytical approaches to demonstrate bioequivalence of nasal suspension formulations. The place of performance will be Silver Spring, Maryland. No...

The National Center for Advancing Translational Sciences (NCATS), part of the U.S. Department of Health and Human Services, awarded a $83,000.00 firm fixed-price purchase order to Poochon Scientific LLC, a minority-owned small business, for Protein Identification of Mixture Samples by LC/MS/MS and Proteomic Profiling of Antisense Oligonucleotide (ASO) Treated Brain Organoids. This non-competitive, commercial item acquisition is being conducted under simplified acquisition procedures by the...

Neuronexus Technologies, Inc., doing business as Nuvectra, has been awarded a $75,000 firm fixed price purchase order by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). The contract calls for Nuvectra to provide an X-DAQ ONE Series electrophysiology recording system, including hardware, software, and silicon recording probes, to support NIDA's biomedical research efforts. Performance...

This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Advanced Accelerator Applications USA, Inc., a foreign-owned, for-profit manufacturer of radiopharmaceuticals and nuclear medicine products. The $178,500 contract is for the procurement of NETSPOT Injection (Gallium Ga 68 Dotatate), a radiopharmaceutical used for diagnostic imaging. This sole-source acquisition was made under simplified procedures for commercial items, without a small...

This is a federal contract award from the National Institute on Drug Abuse (NIDA), a civilian agency, to Altasciences Clinical Kansas Inc., a for-profit contract research organization (CRO). The $1,340,461.88 firm fixed-price delivery order is for a clinical trial to assess the safety, tolerability, and pharmacokinetics of an investigational agent for substance use disorder (SUD) treatment. The contract is part of NIDA's $21 million indefinite delivery contract N01DA-23-8935, which supports...

The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded a $503,901 Delivery Order to Sri International under the Pharmacology and Toxicology for Therapeutics Program Indefinite Delivery Indefinite Quantity master contract. Sri International will provide Follow-On Studies - Ind-Enabling GLP Toxicology from its West Menlo Park, California location between September 2022 and September 2024. Charles River...